XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Cash Flows - USD ($)
2 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ (30,541) $ 9,424,072
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares 25,000
Income from investments held in Trust Account (26,002)
Change in fair value of derivative warrant liabilities (11,489,110)
Financing costs - derivative warrant liabilities 769,323
Changes in operating assets and liabilities:    
Prepaid expenses (6,759) (292,728)
Accrued expenses 12,300 37,575
Deferred legal fees 284,749
Net cash used in operating activities (1,292,121)
Cash Flows from Investing Activities:    
Cash deposited in Trust Account (241,500,000)
Net cash used in investing activities (241,500,000)
Cash Flows from Financing Activities:    
Proceeds from note payable related party 150,000
Repayment of note payable to related party (195,000)
Proceeds received from initial public offering, gross 241,500,000
Proceeds received from private placement 6,830,004
Reimbursement from underwriter 603,750
Offering costs paid (5,228,935)
Net cash provided by financing activities 243,659,819
Net increase in cash 867,698
Cash - beginning of the period
Cash - end of the period 867,698
Supplemental disclosure of noncash financing activities:    
Offering costs included in accounts payable 15,000
Offering costs included in accrued expenses 250,000 70,000
Offering costs included in deferred legal fees 113,000 320,000
Offering costs paid by related party under promissory note 45,000
Deferred underwriting commissions 9,056,250
Remeasurement of Class A ordinary shares to redemption amount $ 25,122,648